Clinical Trials Browser

Interventional × Prostatic Neoplasms × Decitabine × Clear all

NCT03709550 2022-10-05

Enzalutamide and Decitabine in Treating Patients With Metastatic Castration Resistant Prostate Cancer

Phase 1/2 Withdrawn

Prostatic Neoplasms